Integer Holdings (ITGR) Cash from Financing Activities (2010 - 2026)
Integer Holdings' (ITGR) quarterly Cash from Financing Activities came in at $3.8 million in Q2 2026, down 97.47% year-on-year from $151.6 million in Q2 2025, and up 106.21% quarter-over-quarter from -$61.7 million in Q4 2025.
Integer Holdings (ITGR) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Integer Holdings has disclosed Cash from Financing Activities across 17 years of filings, most recently posting $3.8 million for Q2 2026.
- Cash from Financing Activities for Q2 2026 came in at $3.8 million, down 97.47% year-over-year; the trailing twelve-month figure through Apr 2026 was -$104.2 million (down 6591.59% YoY), and the FY2025 annual result was $43.6 million, up 226.99% from the prior year.
- Cash from Financing Activities came in at $3.8 million for Q2 2026 at Integer Holdings, up from -$61.7 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $163.3 million in Q1 2024 to a low of -$82.3 million in Q4 2024.
- The 5-year median for Cash from Financing Activities is -$10.7 million (2025), against an average of $8.0 million.
- Across the five-year window, Cash from Financing Activities surged 3321.4% in 2023 and tumbled 569.69% in 2024, its largest moves.
- Integer Holdings' Cash from Financing Activities stood at -$13.9 million in 2022, then jumped by 225.74% to $17.5 million in 2023, then sank by 569.69% to -$82.3 million in 2024, then rose by 25.01% to -$61.7 million in 2025, then surged by 106.21% to $3.8 million in 2026.
- The last three Cash from Financing Activities figures came in at $3.8 million (Q2 2026), -$61.7 million (Q4 2025), and -$10.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Integer Holdings | 3.12 Bn | 3.11 Bn | 109.60 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 3.83 Mn |
| Apr 3, 2026 | 3.83 Mn |
| Dec 31, 2025 | -61.72 Mn |
| Dec 31, 2025 | -61.72 Mn |
| Sep 26, 2025 | -10.71 Mn |
| Sep 26, 2025 | -10.71 Mn |
| Jun 27, 2025 | -35.59 Mn |
| Jun 27, 2025 | -35.59 Mn |
| Mar 28, 2025 | 151.58 Mn |
| Mar 28, 2025 | 151.58 Mn |
| Dec 31, 2024 | -82.30 Mn |
| Dec 31, 2024 | -82.30 Mn |
| Sep 27, 2024 | -43.14 Mn |
| Sep 27, 2024 | -43.14 Mn |
| Jun 28, 2024 | -24.53 Mn |
| Jun 28, 2024 | -24.53 Mn |
| Mar 29, 2024 | 163.29 Mn |
| Mar 29, 2024 | 163.29 Mn |
| Dec 31, 2023 | 17.52 Mn |
| Dec 31, 2023 | 17.52 Mn |